Skip to content
QCOM$156.03-17.16(-9.91%)Qualcomm Q4: This Dip Is Not The One To Buy Yet7:45:04 AM ETAXP$337.49+4.87(+1.46%)American Express vs. PayPal: Which Financial Stock Is a Better Buy for 2027?7:45:01 AM ETSPCX$132.00-3.92(-2.88%)Stack Capital Group Inc. Reports Q3-2026 Financial Results7:45:00 AM ETCOP$138.55+1.61(+1.18%)BUZZ-ConocoPhillips rises on Q3 profit beat7:40:48 AM ETTGT$165.25+2.20(+1.35%)Target Looks More Attractive Than You'd Think7:31:07 AM ETCOP$138.55+1.61(+1.18%)UPDATE 2-ConocoPhillips beats estimates on higher oil prices, raises dividend7:30:23 AM ETCOP$138.55+1.61(+1.18%)ConocoPhillips Q3 profit beats on higher prices, hikes dividend7:26:13 AM ETMETA$636.80+6.80(+1.08%)UPDATE 2-Meta sells first bonds in euros, raises €9 billion7:25:25 AM ETDTE$137.45-0.06(-0.04%)UPDATE 1-DTE Energy to sell its non-utility business for about $3 billion7:23:30 AM ETAAPL$352.76+3.25(+0.93%)Jim Cramer's Surprise Midterm Winner: Apple, Because Fewer Data Centers Could Mean Cheaper Memory7:19:09 AM ETTSLA$376.71-8.48(-2.20%)Ferrari vs. Tesla: Can the Luce Outsell the Roadster?7:18:00 AM ETMU$754.99-40.47(-5.09%)Could Buying Micron Stock Today Help Set You Up for Life?7:17:00 AM ETMSFT$556.50+0.70(+0.13%)Microsoft Is Executing an Irreproducible Balance-Sheet-Backed Infrastructure Pre-Sale at Scale7:15:58 AM ETAAPL$352.76+3.25(+0.93%)Apple Vs. Tesla: Low CapEx Only Matters if Non-Cyclical Cash Flows Come With It7:15:57 AM ETIREN$20.59-1.11(-5.12%)IREN is Only Fit for a Specific Investor Currently7:15:22 AM ETCOP$138.55+1.61(+1.18%)BRIEF-Conocophillips Q3 Adjusted EPS USD 3.27 Vs. IBES Estimate USD 2.977:13:20 AM ETMU$754.99-40.47(-5.09%)Micron Just Closed Below $800 for the First Time Since July7:12:48 AM ETAAPL$352.76+3.25(+0.93%)Amazon, Apple, FTAI Aviation And A Basic Material Stock: CNBC's ‘Final Trades'7:12:08 AM ETCOP$138.55+1.61(+1.18%)ConocoPhillips beats profit estimates, boosts quarterly dividend7:11:13 AM ETCRWD$234.00-7.00(-2.90%)Too Late to Buy CrowdStrike Stock? Here's the 1 Thing to Watch.7:10:00 AM ETGOOG$289.89+2.59(+0.90%)These 6 Stocks Make Up a Big Share of the S&P 5007:09:00 AM ETCOP$138.55+1.61(+1.18%)UPDATE 1-ConocoPhillips beats profit estimates, boosts quarterly dividend7:07:07 AM ETLLY$1,434.00+15.86(+1.12%)Iconic California Brand, French Florist, Celebrates Grand Opening of First Indiana Location7:07:00 AM ETCVS$80.86+0.87(+1.09%)ProjectLeo, the First Private AI Health Platform to Declare Independence From Big Tech7:04:00 AM ET

ELAB · NASDAQ

PMGC Holdings Inc.

$1.85 -0.07 (-3.65%)

Company overview

PMGC Holdings Inc., a biopharmaceutical company, focuses on the development and acquisition of cutting-edge aesthetic medicines and therapeutic products. Its lead product, EL-22, is a first-in-class engineered probiotic approach designed to address obesity by preserving muscle mass during weight loss treatments, including GLP-1 receptor agonists. The company also engages in medical scientific research and development activities and operates investment firms. Formerly known as Elevai Labs, Inc., the company changed its name to PMGC Holdings Inc. in December 2024. Incorporated in 2020, PMGC Holdings Inc. is based in Newport Beach, California.

Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Market cap
$1.5M
Employees
2
Headquarters
Newport Beach, CA
CEO
Graydon Bensler
Listed
November 21, 2023
P/E
-0.01
Dividend yield
0.00%

Company financials

Revenue
$1.3M
Gross profit
$161,304
Operating income
-$9.5M
EBITDA
-$9M
Net income
-$11.1M
EPS
-$218.85
Total assets
$26M
Total debt
$8M
Gross margin
12.68%
Net margin
-873.11%
Earnings yield
-11,398.44%

Revenue segmentation

By product (FY 2023)

No product segmentation.

By region (FY 2023)

Showing FY 2023

Price chart

0.937.0513.1719.2925.41
ELAB 1D NASDAQ O1.87H2.10L1.85C1.92-0.02 (-1.03%)Vol87.49K

News

15-min delaySigned-out view is delayed 15 minutes. Log in on Pro for the live news desk.

Source
Date
Type
View
Ticker Type Headline Source Published
ELABPMGC Holdings Inc. Press release NorthStrive Biosciences Announces Results from EL-32 Preclinical Combination Study with Semaglutide and Plans for Next Phase of Development GlobeNewswire
ELABPMGC Holdings Inc. Stock news BRIEF-PMGC - Enters Subscription Agreement With Nuclea Energy Canada On Oct 30, 2026 - SEC Filing Reuters
ELABPMGC Holdings Inc. Press release NorthStrive Acquisition Corp I Announces Business Combination with Nuclea Energy GlobeNewswire
ELABPMGC Holdings Inc. Press release PMGC Holdings Inc. Announces DBA as NorthStrive Holdings, Inc., Trademark License Agreement, and Website Update GlobeNewswire
ELABPMGC Holdings Inc. Press release PMGC Holdings (Nasdaq: ELAB) Announces Completion of $100 Million SPAC IPO, Launching NorthStrive Acquisition Corp. I (Nasdaq: NSAI) as First in Planned SPAC Sponsorship Franchise to Expand M&A Strategy GlobeNewswire
ELABPMGC Holdings Inc. Press release NorthStrive Biosciences Partners with Charles River GlobeNewswire
ELABPMGC Holdings Inc. Press release PMGC Holdings Inc. (Nasdaq: ELAB) Secures Five-Year Royalty Stream from Elevai Skincare Sale Under Executed Payment Agreement with Longevity Health Holdings GlobeNewswire
ELABPMGC Holdings Inc. Press release NorthStrive Biosciences Expands AI-Driven Drug Discovery Program with Yuva Biosciences, Advancing Four Novel AI-Discovered Compounds Toward Lead Nomination for Potential Cardiac Disease and Obesity Therapeutic Applications GlobeNewswire
ELABPMGC Holdings Inc. Press release PMGC Holdings Terminates Previously Announced Acquisition LOI Following Due Diligence Review; Reaffirms Disciplined M&A Strategy and Expands Investment Across Aerospace & Defense Manufacturing Portfolio GlobeNewswire
ELABPMGC Holdings Inc. Press release PMGC Holdings Announces Term Sheet with Orbit2Orbit for NorthStrive Biosciences to Launch a Spaceflight Study of Its Myostatin and Activin A Assets, EL-22 and EL-32, Targeting Microgravity-Induced Muscle Loss GlobeNewswire
ELABPMGC Holdings Inc. Press release NorthStrive Biosciences Announces The Filing of Two U.S. Patent Applications Targeting Microgravity-Induced Muscle Loss During Long-Duration Spaceflight GlobeNewswire
ELABPMGC Holdings Inc. Press release PMGC Holdings Inc. Announces Anticipated Reverse Stock Split GlobeNewswire
ELABPMGC Holdings Inc. Press release PMGC Holdings Inc. [NASDAQ: ELAB] Reports Q2 2026 Results and Files Form 10-Q; Total Assets Reach $36.6 Million, Up 184% from Year-End 2025 and 290% Year-over-Year, as Quarterly Revenue Nearly Doubles Sequentially GlobeNewswire
ELABPMGC Holdings Inc. Press release NorthStrive Defense Tech Engages Defense Software and Security Firm Deploy360 to Validate Patented GPS-Denied Drone Navigation Technology Under Option to License GlobeNewswire
ELABPMGC Holdings Inc. Stock news NorthStrive Defense Tech Executes Definitive Exclusive License Agreement with Florida State University Research Foundation for Multi-Domain Drone Payload Technology Across Defense, Aerospace and Maritime Applications GlobeNewswire
ELABPMGC Holdings Inc. Press release NorthStrive Defense Tech Executes Definitive Exclusive License Agreement with Florida State University Research Foundation for Multi-Domain Drone Payload Technology Across Defense, Aerospace and Maritime Applications GlobeNewswire
ELABPMGC Holdings Inc. Press release NorthStrive Biosciences to Advance EL-22 Manufacturing Characterization with Quantitative FACS Analysis of Latent Myostatin Antigen Expression GlobeNewswire
ELABPMGC Holdings Inc. Stock news Delta Air Lines, Netflix and 3 Stocks to Watch Heading Into Friday Benzinga
ELABPMGC Holdings Inc. Press release Wall Street is Watching These Biotechs GlobeNewswire
ELABPMGC Holdings Inc. Press release NorthStrive Biosciences Announces Positive Results from Phase III of AI-Driven Drug Discovery Program with Yuva Biosciences GlobeNewswire
FAQ

Questions about PMGC Holdings Inc.

What does PMGC Holdings Inc. do?
PMGC Holdings Inc., a biopharmaceutical company, focuses on the development and acquisition of cutting-edge aesthetic medicines and therapeutic products. Its lead product, EL-22, is a first-in-class engineered probiotic approach designed to address obesity by preserving muscle mass during weight loss treatments, including GLP-1 receptor agonists. The company also engages in medical scientific research and development activities and operates investment firms. Formerly known as Elevai Labs, Inc., the company changed its name to PMGC Holdings Inc. in December 2024. Incorporated in 2020, PMGC Holdings Inc. is based in Newport Beach, California.
What is ELAB's market cap?
PMGC Holdings Inc. (ELAB) is a listed stock with a live quote. The latest market cap on this page is $1.5M.
Where is PMGC Holdings Inc. headquartered?
PMGC Holdings Inc. is headquartered in Newport Beach, CA.
How do I get ELAB news from the API?
Call GET /v1/news?tickers=ELAB. Add type=news, type=press_release, or type=legal to take one feed. Pro keys search articles since 2020 in real time. Free keys are delayed 15 minutes and return the last year. Signed-out visitors and Free accounts see that same year on this page. Pro sees articles since 2020.
How far back does ELAB news go?
Signed-out visitors and Free accounts see the last year of stock news, press releases, and legal notices for ELAB, 15 minutes behind, and each headline links to the publisher. Pro, including the 7-day trial, sees articles since 2020 as headlines are ingested. A Free API key returns the last year. Pro keys search articles since 2020.
Is the ELAB price on this page from the API?
The price and daily change update during the US session for every visitor. That quote is context on this page. It is not part of the news API. The chart is one candle per session from the start of 2020. 1W, 1M, and 1Y group those sessions.
Can I use the Pro plan commercially?
No. The Pro plan cannot be used for commercial work. A product you sell, work you do for a client, or redistribution of the feed needs a custom plan and a license. Email [email protected].

Real-time stock news for $15 a month.

Start a 7-day Pro trial. A card is required. REST, WebSocket, and MCP are included, with 250 REST requests a day, 1 WebSocket connection, 5 requests per second, and 2,500 WebSocket messages a day. You won't be charged during the trial. Unless you cancel, the card is billed for Pro when it ends.